BCI-FES Therapy for Stroke Rehabilitation

  • STATUS
    Recruiting
  • participants needed
    80
  • sponsor
    University of California, Irvine
Updated on 19 February 2024
stroke
weakness
spasticity
foot drop
electrical stimulation
intracranial hemorrhage
ischemic stroke
stroke rehabilitation

Summary

There are over 7 million stroke survivors in the US alone, with approximately 795,000 new cases annually. Despite the best available physiotherapy, 30-60% of stroke survivors remain affected by difficulty walking, with foot weakness often being the main cause. Given that post-stroke gait impairments remain poorly addressed, new methods that can provide lasting improvements are necessary. Brain-computer interface (BCI) technology may be one such novel approach. BCI technology enables "direct brain control" of external devices such as assistive devices and prostheses by translating brain waves into control signals. When BCI systems are integrated with functional electrical stimulation (FES) systems, they can be used to deliver a novel physical therapy to improve movement after stroke. BCI-FES systems are hypothesized to stimulate recovery after stroke beyond that of conventional physical therapy.

Description

Preliminary research indicates that applying this technique to foot weakness after stroke is safe and may improve walking function. Hence, this warrants further investigation to: 1. determine if BCI-FES therapy can provide lasting gains in walking in chronic stroke patients; 2. determine what factors influence BCI-FES therapy; and 3. explicitly elucidate the underlying neural repair mechanisms. First, a Phase II clinical trial in patients with foot drop due to chronic stroke will compare the effect of BCIFES dorsiflexion therapy to that of dose- and intensity-matched standard physical therapy (Aim 1). Comparing the improvement in walking speed and other secondary outcome measures between the two groups will test if BCI-FES therapy provides functional and neurological gains beyond those of standard physical therapy. The relationship between the patient baseline characteristics (walking speed, ankle function, stimulated muscle responses, brain wave features, sensation) and the outcomes will determine what features influence responsiveness to BCI-FES dorsiflexion therapy (Aim 2). Finally, the underlying mechanism driving the improvements of BCI-FES will be studied (Aim 3). Determining that BCI-FES therapy can provide improvements beyond that of standard therapy may lead to a new treatment for stroke patients. The underlying mechanism can inform the design of future physical therapy techniques or improve current ones. Finally, BCI-FES therapy may ultimately become a novel form of physical therapy to reduce post-stroke disability, and in turn reduce the public health burden of stroke.

Details
Condition INTRACRANIAL HEMORRHAGE, Ischemic Stroke
Age 18-80 years
Treatment BCI-FES dorsiflexion therapy, Physiotherapy one hour, Physiotherapy two hours
Clinical Study IdentifierNCT04279067
SponsorUniversity of California, Irvine
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Age18-80 years inclusively at time of consent
Radiologically confirmed first unilateral stroke, ischemic or intracranial hemorrhage (ICH) in etiology, with day of onset 26-104 weeks prior to day of randomization
Gait velocity<0.8 m/s at screening and baseline visits
Foot-drop in affected limb as defined by dorsiflexion active range of motion (AROM) via goniometry in seated position foot dangling is less than passive range of motion and less than 15 degrees
Plantarflexors spasticity<3 on modified Ashworth Scale
Can walk >10 m (no ankle foot orthosis (AFO), but cane or walker permitted) at a supervised level
Can tolerate FES with pain no more than 4 on pain analog scale and has adequate muscle response of TA dorsiflexion 10 degrees
Passive Range of Motion at least +10 degrees ankle dorsiflexion in subtalar neutral

Exclusion Criteria

A major, active, coexistent medical, neurological (apart from stroke) or psychiatric disease (apart from stroke), including alcoholism or dementia, orthopedic injuries, that substantially affects gait
A major medical disorder that substantially reduces the likelihood that a subject will be able to comply with all study procedures or safely complete study procedures. This includes, but not limited to documented serious cardiac conditions, serious pulmonary conditions, legal blindness, end stage renal or liver disease, pulmonary embolism or deep venous thrombosis
Resting systolic blood pressure above 170, diastolic blood pressure above 100 at screening and baseline evaluations
Implanted electronic device (e.g. pacemaker) or skull metallic implants (e.g. cranioplasty plate)
Deficits in communication that interfere with reasonable study participation: language or attention impairment (score>1 on NIH Stroke Scale items 9 and 11, respectively)
Significant cognitive impairment, defined as Montreal Cognitive Assessment score < 22 (For those with aphasia: Because Montreal Cognitive Assessment scores may be difficult to interpret for patients with aphasia, at the discretion of the site's study PI, exclusion criterion #5 ("MoCA score cannot be <22") can be waived)6. A new symptomatic stroke occurs apart from the index stroke during the screening process and prior to randomization
Life expectancy < 6 months
Skin breakdown over electrical stimulation sites
Received chemical denervation (eg Botox) to arms, legs, or trunk in the preceding 6 months, or expectation that chemical denervation will be administered to the arm, leg, or trunk prior to expected completion of the study
Unable or unwilling to perform study procedures/therapy, or expectation of non-compliance with study procedures/therapy
Pregnancy
Significant pain (visual analog scale >4), chest pain, or shortness of breath with walking
Receiving any outside concurrent physical therapy
Any general medical condition and psychosocial situation that substantially interferes with reasonable participate in study appointments
Non-English speaking, such that subject does not speak sufficient English to comply with study procedures
Concurrent enrollment in another investigational interventional study
Severe depression, defined as Geriatric Depression Scale Score >11
Prior or concurrent use of FES orthosis for gait
A new symptomatic stroke occurs apart from the index stroke during the screening process and prior to randomization
If TMS Eligible (note that potential subjects who do not qualify for TMS will
not be excluded from the main study, they will only be excluded from
undergoing TMS procedures)
\. TMS: Metallic hardware on the scalp (e.g. vascular clips or cranioplasty
mesh)
\. TMS: Implanted medication pumps, intracardiac line, or central venous
catheter
\. TMS: History of cortical stroke or other cortical lesion such as brain
tumor
\. TMS: Prior diagnosis of seizure or epilepsy
\. TMS: Any electrical, mechanical, or magnetic implants
\. TMS: History of neurosurgery
\. TMS: uncontrolled Migraine headaches
\. TMS: Any current medications that affect seizure threshold such as
tricyclic antidepressants and neuroleptics
\. TMS: Unstable medical conditions
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 â€¢ 

Private

Reply by • • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.